BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5496789)

  • 1. [Comparative therapeutic survey of 2 intermittent drug therapies. (Isoniazid (INH), ethionamid (ETA) and streptomycin (SM), isoniazid (INH). Results with 965 patients. Antituberculosis services in Morocco and Senegal].
    Burzoni F; Durante C; Chicou J; Hétrick G; Munoz I; Ras R; Brunel ; Rabier
    Rev Tuberc Pneumol (Paris); 1970; 34(5):671-3. PubMed ID: 5496789
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of 2 intermittent therapeutic regimens: ethionamide-isoniazid and streptomycin-isoniazid].
    Lahlou M
    Bull Int Union Tuberc; 1970 Jun; 43():289-94. PubMed ID: 5425557
    [No Abstract]   [Full Text] [Related]  

  • 4. [Attempt at intermittent chemotherapeutic treatment of patients with bacilli resistant to streptomycin and isoniazid (cooperative survey by the antitubercular services of Marrakech, Meknes, Tangiers)].
    Burzoni FJ; Chicou FJ; Durante C; Hetrick G; Ras R
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):975-86. PubMed ID: 5403000
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies.
    Kradolfer F
    Antibiot Chemother; 1970; 16():352-60. PubMed ID: 5523730
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of a study carried out in Morocco on intermittent treatment of pulmonary tuberculosis with a bi-weekly combination of isoniazid and streptomycin adminisrered intramuscularly].
    Burzoni FJ; Durante C
    Bull Int Union Tuberc; 1968 Dec; 41():322-4. PubMed ID: 5710256
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results.
    Grumbach F; Canetti G; Le Lirzin M
    Tubercle; 1969 Sep; 50(3):280-93. PubMed ID: 4981497
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance (Report 2) (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1977 Dec; 52(12):619-26. PubMed ID: 604603
    [No Abstract]   [Full Text] [Related]  

  • 11. [New combinations of drugs for the treatment of drug-resistant tuberculosis].
    Schmelev NA
    Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
    Makiyama H
    Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems of treatment of drug resistance in the developing countries.
    Fox W
    Tubercle; 1969 Mar; 50():Suppl:55-65. PubMed ID: 5402546
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic results of freshly diagnosed pulmonary tuberculosis EMB in association with SM and INH administered both continuously and intermittently].
    Zierski M
    Gruzlica; 1970; 38(7):723-4. PubMed ID: 5453682
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
    Toyota E; Suzuki T; Tagawa K; Takahara M; Ito M; Arai T; Kabe J; Baba H
    Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intermittent long-term cheomotherapy in experimental tuberculosis of the mouse].
    Grumbach F
    Bull Int Union Tuberc; 1968 Dec; 41():303-8. PubMed ID: 5710255
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of a trial in Morocco of intermittent treatment of pulmonary tuberculosis with combined streptomycin and isoniazid intramuscularly.
    Burzoni FJ; Durante C
    Tubercle; 1968 Mar; 49():82-3. PubMed ID: 4872959
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental studies on the effect of the combined use of 1314 Th and INH to INH-resistant tubercle bacilli from the view-point of 14C-INH uptake].
    Takae S
    Kekkaku; 1967 Apr; 42(4):119-28. PubMed ID: 4965143
    [No Abstract]   [Full Text] [Related]  

  • 19. Late results of long-term intermittent chemotherapy of advanced, murine tuberculosis: limits of the murine model.
    Grumbach F; Canetti G; Grosset J; le Lirzin M
    Tubercle; 1967 Mar; 48(1):11-26. PubMed ID: 6034625
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifomycin in continuous and intermittent combined treatment of experimental tuberculosis in mice].
    Grumbach F
    Acta Tuberc Pneumol Belg; 1969; 60(3):390-6. PubMed ID: 5371670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.